Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-10-11 Sale | 2023-10-12 4:00 pm | Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer | 785 | $2.02 | $1,586 | 100,069 (Direct) | View |
| 2023-09-11 Sale | 2023-09-13 4:06 pm | Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer | 711 | $2.2 | $1,564 | 100,854 (Direct) | View |
| 2023-08-11 Sale | 2023-08-14 4:00 pm | Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer | 682 | $2.36 | $1,610 | 101,565 (Direct) | View |
| 2023-07-11 Sale | 2023-07-12 4:29 pm | Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer | 687 | $2.34 | $1,608 | 102,247 (Direct) | View |
| 2023-06-12 Sale | 2023-06-14 4:28 pm | Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer | 610 | $2.64 | $1,610 | 102,934 (Direct) | View |
| 2023-05-11 Sale | 2023-05-15 4:00 pm | Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer | 562 | $2.89 | $1,624 | 103,544 (Direct) | View |
| 2023-04-11 Sale | 2023-04-12 5:02 pm | Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer | 840 | $1.839 | $1,545 | 104,106 (Direct) | View |
| 2023-03-13 Sale | 2023-03-15 4:00 pm | Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer | 892 | $1.7532 | $1,564 | 104,946 (Direct) | View |
| 2023-02-13 Sale | 2023-02-15 4:01 pm | Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer | 8,474 | $2.45 | $20,761 | 105,838 (Direct) | View |
| 2022-07-01 Sale | 2022-07-06 5:00 pm | Trevi Therapeutics Inc. | TRVI | TPG GP A LLC BONDERMAN DAVID COULTER JAMES G WINKELRIED JON Former 10% Owner | 500,000 | $2.888 | $1,444,012 | 3,824,883 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-15 Option Award | 2024-02-16 4:44 pm | N/A 2034-02-14 | Trevi Therapeutics Inc. | TRVI | Galletta Christopher See Remarks | 28,500 | $0 | 28,500 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-16 4:43 pm | N/A 2034-02-14 | Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer | 175,000 | $0 | 175,000 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-16 4:43 pm | N/A 2034-02-14 | Trevi Therapeutics Inc. | TRVI | Clark David J Chief Medical Officer | 175,000 | $0 | 175,000 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-16 4:43 pm | N/A 2034-02-14 | Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L President & CEO | 630,000 | $0 | 630,000 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-16 4:42 pm | N/A 2034-02-14 | Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-16 4:42 pm | N/A 2034-02-14 | Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer | 175,000 | $0 | 175,000 (Direct) | View |
| 2023-10-11 Exercise | 2023-10-12 4:00 pm | N/A 2032-02-10 | Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer | 2,292 | $0 | 100,069 (Direct) | View |
| 2023-10-11 Exercise | 2023-10-12 4:00 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer | 2,292 | $0.511 | 100,069 (Direct) | View |
| 2023-09-11 Exercise | 2023-09-13 4:06 pm | N/A 2032-02-10 | Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer | 2,291 | $0 | 100,854 (Direct) | View |
| 2023-09-11 Exercise | 2023-09-13 4:06 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer | 2,291 | $0.511 | 100,854 (Direct) | View |
| 2023-08-11 Exercise | 2023-08-14 4:00 pm | N/A 2032-02-10 | Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer | 2,292 | $0 | 101,565 (Direct) | View |
| 2023-08-11 Exercise | 2023-08-14 4:00 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer | 2,292 | $0.511 | 101,565 (Direct) | View |
| 2023-07-11 Exercise | 2023-07-12 4:29 pm | N/A 2032-02-10 | Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer | 2,292 | $0 | 102,247 (Direct) | View |
| 2023-07-11 Exercise | 2023-07-12 4:29 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer | 2,292 | $0.511 | 102,247 (Direct) | View |
| 2023-06-28 Option Award | 2023-06-30 4:14 pm | N/A 2033-06-27 | Trevi Therapeutics Inc. | TRVI | Mathers Edward T Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2023-06-28 Option Award | 2023-06-30 4:00 pm | N/A 2033-06-27 | Trevi Therapeutics Inc. | TRVI | Cassella James V Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2023-06-28 Option Award | 2023-06-30 4:00 pm | N/A 2033-06-27 | Trevi Therapeutics Inc. | TRVI | Heffernan Michael Thomas Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2023-06-28 Option Award | 2023-06-30 4:00 pm | N/A 2033-06-27 | Trevi Therapeutics Inc. | TRVI | Meeker David P Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2023-06-28 Option Award | 2023-06-30 4:00 pm | N/A 2033-06-27 | Trevi Therapeutics Inc. | TRVI | Colangelo Dominick Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2023-06-28 Option Award | 2023-06-30 4:00 pm | N/A 2033-06-27 | Trevi Therapeutics Inc. | TRVI | VANLENT ANNE Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2023-06-20 Exercise | 2023-06-21 4:00 pm | N/A 2032-02-10 | Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer | 6,250 | $0 | 95,650 (Direct) | View |
| 2023-06-20 Exercise | 2023-06-21 4:00 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer | 6,250 | $0.511 | 95,650 (Direct) | View |
| 2023-06-12 Exercise | 2023-06-14 4:28 pm | N/A 2032-02-10 | Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer | 2,291 | $0 | 102,934 (Direct) | View |
| 2023-06-12 Exercise | 2023-06-14 4:28 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer | 2,291 | $0.511 | 102,934 (Direct) | View |
| 2023-05-11 Exercise | 2023-05-15 4:00 pm | N/A 2032-02-10 | Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer | 2,291 | $0 | 103,544 (Direct) | View |
| 2023-05-11 Exercise | 2023-05-15 4:00 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer | 2,291 | $0.511 | 103,544 (Direct) | View |
| 2023-04-11 Exercise | 2023-04-12 5:02 pm | N/A 2032-02-10 | Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer | 2,292 | $0 | 104,106 (Direct) | View |
| 2023-04-11 Exercise | 2023-04-12 5:02 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer | 2,292 | $0.511 | 104,106 (Direct) | View |
| 2023-03-13 Exercise | 2023-03-15 4:00 pm | N/A 2032-02-10 | Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer | 2,291 | $0 | 104,946 (Direct) | View |
| 2023-03-13 Exercise | 2023-03-15 4:00 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer | 2,291 | $0.511 | 104,946 (Direct) | View |
| 2023-03-07 Exercise | 2023-03-08 4:00 pm | N/A 2032-02-10 | Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer | 18,750 | $0 | 95,650 (Direct) | View |
| 2023-03-07 Exercise | 2023-03-08 4:00 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer | 18,750 | $0.511 | 95,650 (Direct) | View |
| 2023-02-16 Option Award | 2023-02-16 5:34 pm | N/A 2033-02-15 | Trevi Therapeutics Inc. | TRVI | Galletta Christopher See Remarks | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-02-16 Option Award | 2023-02-16 5:30 pm | N/A 2033-02-15 | Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer | 100,000 | $0 | 100,000 (Direct) | View |
Ownership | 2023-02-16 5:26 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer | 0 | $0 | 188,150 (Direct) | View |
| 2023-02-16 Option Award | 2023-02-16 5:23 pm | N/A 2033-02-15 | Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer | 187,500 | $0 | 187,500 (Direct) | View |
| 2023-02-16 Option Award | 2023-02-16 5:18 pm | N/A 2033-02-15 | Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer | 187,500 | $0 | 187,500 (Direct) | View |
| 2023-02-16 Option Award | 2023-02-16 5:13 pm | N/A 2033-02-15 | Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L President & CEO | 375,000 | $0 | 375,000 (Direct) | View |
| 2023-02-13 Exercise | 2023-02-15 4:01 pm | N/A 2032-02-10 | Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer | 27,500 | $0 | 105,838 (Direct) | View |
| 2023-02-13 Exercise | 2023-02-15 4:01 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer | 27,500 | $0.511 | 105,838 (Direct) | View |
| 2022-11-14 Option Award | 2022-11-14 4:43 pm | N/A 2032-11-13 | Trevi Therapeutics Inc. | TRVI | Clark David J Chief Medical Officer | 300,000 | $0 | 300,000 (Direct) | View |
| 2022-09-19 Option Award | 2022-09-19 4:30 pm | 2022-09-19 2031-02-16 | Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Medical Officer | 7,500 | $0 | 37,500 (Direct) | View |
| 2022-09-19 Option Award | 2022-09-19 4:26 pm | 2022-09-19 2031-02-16 | Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L President & CEO | 32,000 | $0 | 160,000 (Direct) | View |
| 2022-06-23 Option Award(A) | 2022-07-01 4:59 pm | N/A 2032-06-22 | Trevi Therapeutics Inc. | TRVI | VANLENT ANNE Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-23 Option Award(A) | 2022-07-01 4:58 pm | N/A 2032-06-22 | Trevi Therapeutics Inc. | TRVI | Meeker David P Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-23 Option Award(A) | 2022-07-01 4:56 pm | N/A 2032-06-22 | Trevi Therapeutics Inc. | TRVI | Heffernan Michael Thomas Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-23 Option Award(A) | 2022-07-01 4:54 pm | N/A 2032-06-22 | Trevi Therapeutics Inc. | TRVI | Colangelo Dominick Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-23 Option Award(A) | 2022-07-01 4:52 pm | N/A 2032-06-22 | Trevi Therapeutics Inc. | TRVI | Cassella James V Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-29 Option Award | 2022-07-01 4:51 pm | 2022-06-29 2031-02-16 | Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Medical Officer | 30,000 | $0 | 30,000 (Direct) | View |